MANH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Manhattan Associates Inc (MANH) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has shown solid financial growth in its latest quarter, the technical indicators suggest a bearish trend, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Holding off for a better entry point or more favorable signals is recommended.
The technical indicators for MANH are bearish. The MACD is negative and expanding downward, RSI is neutral at 29.079, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 142.569, with key support at 131.777 and resistance at 153.36. This suggests downward pressure on the stock price.
The company reported strong Q4 financial results with revenue up 5.70% YoY, net income up 8.20% YoY, and EPS up 11.69% YoY. Analysts from DA Davidson and Truist maintain a Buy rating with a $240 price target, citing strong demand and growth drivers in warehouse management and cloud subscriptions.
Morgan Stanley downgraded the price target to $165, citing deceleration in RPO growth and underappreciated headwinds. The MACD and moving averages indicate a bearish trend, and options data shows bearish sentiment. Gross margin dropped by 1.41% YoY in Q4 2025, and there is no recent news or significant trading activity from insiders or hedge funds.
In Q4 2025, the company achieved revenue growth of 5.70% YoY to $270.39 million, net income growth of 8.20% YoY to $51.95 million, and EPS growth of 11.69% YoY to $0.86. However, gross margin declined by 1.41% YoY to 54.41%. The financial performance is solid but not exceptional.
Analyst ratings are mixed. DA Davidson and Truist have Buy ratings with a $240 price target, citing strong demand and growth drivers. Morgan Stanley has an Equal Weight rating with a $165 price target, citing deceleration in RPO growth and headwinds. The consensus reflects cautious optimism but highlights potential risks.
